This page contains information relating to Anti-Depressants
BBC Panorama investigates GSK, the programme is viewable online for UK viewers
Stronger warnings for anti-depressants
CCHR Backs Cruise Warning On Deadly Psychiatric Drugs
Politics,Kick-backs and Harmful Pharms! (...or Mo' money...Mo' money!).
Psychiatrist blows the lid on anti-depressants.
Suicide rate unchanged in 10 years
Treating children as young as 4 for Bi-polar depression...
Despite vow. Drug Makers still withold data!
UK: Drug firms are creating ills for every pill..
Warning from FDA. Withdrawal from Paroxetine(Seroxat) can be severe.
GSK investors bring Paxil(Seroxat) lawsuit.
SSRI anti-depressants involve dopamine as well as serotonin signalling.
October 1998 GSK Internal Memo:Strategy of Concealment !!!!!!
Losing a child... Explorations in grief
Was Traci Johnson driven to suicide by anti-depressants? That is a trade secret, says US officials.
Bush-Backed SSRI Anti-Depressant schemes
Changing Brain Activity Predicts Side Effects of SSRI's.
Click here for information about Activation Syndrome (Akathisia) after taking certain anti-depressants.
Click here for an article regarding paxil / seroxat and links with suicide.
Click here for article regarding the side effect of suicide after taking SSRI's such as seroxat/paxil/prozac.
Click here for article on the violent behavioural side effects seroxat / paxil have.
Click here for article about a 14 year old boy who shot both of his paretns while taking paxil / seroxat.
Click here for article about a man who went on a shooting spree after taking paxil / seroxat.
Click here for article about a mother who wants paxil / seroxat banned after her daughter mutilated herself whilst taking the drug.
Click here for article about Prozac and how it can lead to suicide amongst certain users who cannot metabolise fluoxetine.
Click here Interesting web link about the dangers of doctors comapred to firearms
Click here for info about the benefits of St Johns warts over that of anti-depressants!
Paxil Memo Raises Questions
Firm worried trial data disclosure would hurt antidepressant sales
The Star-Ledger - ED SILVERMAN
02/18/04 - The maker of a popular antidepressant, which British authorities banned last year for use in children, knew the drug wasn't effective but didn't publish studies because sales could be hurt, according to an internal memo.
The 1998 GlaxoSmithkline document noted two clinical trials showed Paxil was no better than a dummy pill in treating depression. But it would be "commercially unacceptable" to disclose the findings, according to the memo which was circulated by a consumer group.